Journal:JBSD:10
From Proteopedia
(Difference between revisions)

(2 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
<StructureSection load='' size='450' side='right' scene='Journal:JBSD:10/Cv/1' caption=''> | <StructureSection load='' size='450' side='right' scene='Journal:JBSD:10/Cv/1' caption=''> | ||
=== Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of ''Leptospira spp.'': Homology modeling, docking and molecular dynamics study === | === Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of ''Leptospira spp.'': Homology modeling, docking and molecular dynamics study === | ||
- | <big>Dibyabhaba Pradhan, Vani Priyadarshini, Manne Munikumar, Sandeep Swargam, Amineni Umamaheswari & Aparna Bitla</big> <ref> | + | <big>Dibyabhaba Pradhan, Vani Priyadarshini, Manne Munikumar, Sandeep Swargam, Amineni Umamaheswari & Aparna Bitla</big> <ref>doi 10.1080/07391102.2012.758056</ref> |
<hr/> | <hr/> | ||
<b>Molecular Tour</b><br> | <b>Molecular Tour</b><br> | ||
- | ''Leptospira interrogans'', a Gram-negative bacterial pathogen is the main cause of human leptospirosis. Lipid A is a highly immunoreactive endotoxic center of lipopolysaccharide (LPS) that anchors LPS into the outer membrane of Leptospira. Discovery of compounds inhibiting lipid-A biosynthetic pathway would be promising for dissolving the structural integrity of membrane leading to cell lysis and death of Leptospira. <scene name='Journal:JBSD:10/Cv/2'>LpxC</scene>, a unique enzyme of lipid-A biosynthetic pathway was identified as common drug target of ''Leptospira''. Herein, homology modeling, docking, and molecular dynamics (MD) simulations were employed to discover potential inhibitors of LpxC. A <scene name='Journal:JBSD:10/Cv/3'>reliable tertiary structure of LpxC in complex with inhibitor BB-78485</scene> was constructed in Modeller 9v8. <scene name='Journal:JBSD:10/Cv/5'>Click here to see animated comparison</scene> between active site of target and template (LpxC from ''Pseudomonas aeruginosa'' [[2ves]]) in the presence of BB-78485. The color code representations as deep pink: target; green: template; cyan: BB-78485 in complex with target; and darkmagenta: BB-78485 in complex with template. Zn ion represented as sphere. A data-set of BB-78485 structural analogs were docked with LpxC in Maestro v9.2 virtual screening workflow, which implements three stage Glide docking protocol. Twelve lead molecules with better XP Gscore compared to BB-78485 were proposed as potential inhibitors of LpxC. Para-(benzoyl)-phenylalanine – that showed lowest XP Gscore (−10.35 kcal/mol) – was predicted to have best binding affinity towards LpxC. MD simulations were performed for LpxC and para-(benzoyl)-phenylalanine docking complex in Desmond v3.0. Trajectory analysis showed the docking complex and inter-molecular interactions was stable throughout the entire production part of MD simulations. The results indicate para-(benzoyl)-phenylalanine as a potent drug molecule against leptospirosis. | + | ''Leptospira interrogans'', a Gram-negative bacterial pathogen is the main cause of human leptospirosis. Lipid A is a highly immunoreactive endotoxic center of lipopolysaccharide (LPS) that anchors LPS into the outer membrane of Leptospira. Discovery of compounds inhibiting lipid-A biosynthetic pathway would be promising for dissolving the structural integrity of membrane leading to cell lysis and death of Leptospira. <scene name='Journal:JBSD:10/Cv/2'>LpxC</scene>, a unique enzyme of lipid-A biosynthetic pathway was identified as common drug target of ''Leptospira''. Herein, homology modeling, docking, and molecular dynamics (MD) simulations were employed to discover potential inhibitors of LpxC. A <scene name='Journal:JBSD:10/Cv/3'>reliable tertiary structure of LpxC in complex with inhibitor BB-78485</scene> was constructed in Modeller 9v8. <scene name='Journal:JBSD:10/Cv/5'>Click here to see animated comparison</scene> between active site of target and template (LpxC from ''Pseudomonas aeruginosa'', PDB entry [[2ves]]) in the presence of BB-78485. The color code representations as <span style="color:deeppink;background-color:black;font-weight:bold;">deep pink: target</span>; <span style="color:lime;background-color:black;font-weight:bold;">green: template</span>; <span style="color:cyan;background-color:black;font-weight:bold;">cyan: BB-78485 in complex with target</span>; and <font color='darkmagenta'><b>darkmagenta: BB-78485 in complex with template</b></font>. Zn ion represented as sphere. A data-set of BB-78485 structural analogs were docked with LpxC in Maestro v9.2 virtual screening workflow, which implements three stage Glide docking protocol. Twelve lead molecules with better XP Gscore compared to BB-78485 were proposed as potential inhibitors of LpxC. Para-(benzoyl)-phenylalanine – that showed lowest XP Gscore (−10.35 kcal/mol) – was predicted to have best binding affinity towards LpxC. MD simulations were performed for LpxC and para-(benzoyl)-phenylalanine docking complex in Desmond v3.0. Trajectory analysis showed the docking complex and inter-molecular interactions was stable throughout the entire production part of MD simulations. The results indicate para-(benzoyl)-phenylalanine as a potent drug molecule against leptospirosis. |
</StructureSection> | </StructureSection> | ||
<references/> | <references/> | ||
__NOEDITSECTION__ | __NOEDITSECTION__ |
Current revision
|
- ↑ Pradhan D, Priyadarshini V, Munikumar M, Swargam S, Umamaheswari A, Bitla A. Para-(benzoyl)-phenylalanine as a potential inhibitor against LpxC of Leptospira spp.: homology modeling, docking, and molecular dynamics study. J Biomol Struct Dyn. 2013 Feb 5. PMID:23383626 doi:10.1080/07391102.2012.758056
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.